Frequent nurse visits decrease white coat effect in stage III hypertension

American Journal of Hypertension

Volumn 17, Issue 6, 2004, Pages 523-528

  Guerra Riccio, Grazia Maria ^a   Artigas Giorgi, Dante Marcelo ^a   Consolin Colombo, Fernanda Marciano ^a   Soares Barreto Filho, José Augusto ^a   Ferreira Lopes, Heno ^a   Fleury Camargo, Ana Lúcia Rego ^a   Moacyr Krieger, Eduardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

adherence of patient; ambulatory blood pressure monitoring; attention of patient; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL FEATURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HEALTH CARE DELIVERY; HEALTH VISITOR; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSE; PHARMACIST; PRIORITY JOURNAL; RANDOMIZATION; SYSTOLIC BLOOD PRESSURE; TIME; TREATMENT OUTCOME; WHITE COAT HYPERTENSION;

EID: 2642588850     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.02.007     Document Type: Article

References (19)

1. Garfield F.B., Caro J.J. Compliance and hypertension. Curr Hypertens Rep. 1:1999;502-506
2. Bittar N. Maintaining long-term control of blood pressure The role of improved compliance. Clin Cardiol. 18:1995;III12-III16
3. Juncos L.I. Patient compliance and angiotensin-converting enzyme inhibitors in hypertension. J Cardiovasc Pharmacol. 15:(Suppl 3):1990;22-25
4. Caro J.J., Speckman Jl. Existing treatment strategies Does noncompliance make a differences. J Hypertens. 16:(Suppl 7):1998;31-34
5. Hill M.N., Bone L.R., Kim T.M., Miller D.J., Dennison C.R., Lenine D.M. Barriers to hypertension care and control in young urban black men. Am J Hypertens. 12:1999;951-958
6. Dunbar-Jacob J., Mortimer-Stephens M.K. Treatment adherence in chronic disease. J Clin Epidemiol. 54:2001;S57-S60
7. Mancia G., Zanchetti A. White-coat hypertension Misnomers, misconceptions and misunderstandings. what should we do next? J Hypertens. 14:1996;1049-1052
8. Benkert R., Buchholz S., Poole M. Hypertension outcomes in a urban nurse-managed center. J Am Acad Nurse Pract. 13:2001;84-89
9. Mundinger M.O., Kane R.L., Lenz E.R., Totten A.M., Tsai W.Y., Cleary P.D., Friedewald W.T., Siu A.L., Shelanski M.L. Primary care outcomes in patients treated by nurse practitioners or physicians A randomized trial. JAMA. 283:2000;59-68
10. Mancia G., Parati G., Pomidossi G., Grassi G., Casadei R., Zanchetti A. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension. 9:1987;209-215
11. Strandberg T.E., Salomaa V. White coat effect, blood pressure and mortality in men Prospective cohort study. Eur Heart J. 21:2000;1714-1718
12. Kuvajima I., Suzuki J., Fujisawa A., Kuramoto K. Is white-coat hypertension innocent? Structure and function of the heart in the elderly. Hypertension. 22:1993;826-831
13. Cerasola G., Cottone S., Nardi E., D'Ignoto G., Volpe V., Mule G., Carollo C. White-coat hypertension and cardiovascular risk. J Cardiovasc Risk. 2:1995;545-549
14. Gosse P., Bougaleb M., Egloff P., Lemetayer P., Clementy J. Clinical significance of white-coat hypertension. J Hypertens. 12:(Suppl 8):1994;S43-S47
15. Verdecchia P., Porcellati C., Schillaci G., Borgioni C., Ciucci A., Battistelli M., Guerrieri M., Gatteschi C., Zampi I., Santucci A., Reboldi G. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 24:1994;793-801
16. Parati G., Ulian L., Sampieri L., Palatini P., Villani A., Vanasia A., Mancia G. Attenuation of the "white-coat effect" by antihypertensive treatment and regression of target organ damage. Hypertension. 35:2000;614-620
17. Parati G., Omboni S., Mancia G. Difference between office and ambulatory blood pressure and response to antihypertensive treatment. J Hypertens. 14:1996;791-797
18. Myers M.G., Reeves R.A. White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens. 4:1991;844-884
19. Morimoto S, Takeda K, Oguni A, Kido H, Harada S, Moriguchi J, Itoh H, Nakata T, Sasaki S, Nakagawa M: Reduction of white coat effect by cilnidipine in essential hypertension. Am J Hypertens 2001;14:1053-1057.